Blockchain Registration Transaction Record

REMSleep Launches DeltaWave Nationwide, Tackling CPAP Compliance Crisis

REMSleep launches DeltaWave nasal pillow system nationwide after FDA & Medicare approvals. Patented technology addresses CPAP compliance crisis with comfortable mask alternative for sleep apnea patients.

This news directly impacts millions of Americans suffering from sleep apnea and the healthcare providers who treat them. With 30-50% of CPAP patients abandoning therapy due to mask discomfort—a problem costing the healthcare system billions in untreated conditions and complications—DeltaWave's nationwide availability offers a tangible solution. For patients, it means potentially staying on life-changing therapy longer, reducing risks of cardiovascular disease, stroke, and daytime fatigue. For DME providers and physicians, it provides a clinically validated alternative when standard masks fail, potentially improving patient outcomes while creating new revenue streams through institutional channels and patient resupply. The Medicare and private insurance coding approvals remove financial barriers, making this innovative technology accessible precisely where it's needed most.